MX2007002808A - Proceso para el aislamiento de tacrolimus cristalino. - Google Patents

Proceso para el aislamiento de tacrolimus cristalino.

Info

Publication number
MX2007002808A
MX2007002808A MX2007002808A MX2007002808A MX2007002808A MX 2007002808 A MX2007002808 A MX 2007002808A MX 2007002808 A MX2007002808 A MX 2007002808A MX 2007002808 A MX2007002808 A MX 2007002808A MX 2007002808 A MX2007002808 A MX 2007002808A
Authority
MX
Mexico
Prior art keywords
tacrolimus
isolation
crystalline tacrolimus
crystalline
tsucubamycin
Prior art date
Application number
MX2007002808A
Other languages
English (en)
Inventor
Ladislav Cvak
Alexandr Jegorov
Martin Buchta
Pavel Blatn
Josef Satke
Original Assignee
Ivax Pharmaceuticals Sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Pharmaceuticals Sro filed Critical Ivax Pharmaceuticals Sro
Publication of MX2007002808A publication Critical patent/MX2007002808A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invencion es un proceso simple para la separacion de tacrolimus y sus analogos, ascomicina y tsucubamicina B y preparacion de tacrolimus cristalino suficientemente puro. El proceso aprovecha sorprendentes propiedades de tacrolimus e incluye extraccion, purificacion y cristalizacion para producir tacrolimus cristalino purificado.
MX2007002808A 2004-09-10 2005-09-09 Proceso para el aislamiento de tacrolimus cristalino. MX2007002808A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60875704P 2004-09-10 2004-09-10
US60875204P 2004-09-10 2004-09-10
PCT/US2005/032258 WO2006031664A1 (en) 2004-09-10 2005-09-09 Process for isolation of crystalline tacrolimus

Publications (1)

Publication Number Publication Date
MX2007002808A true MX2007002808A (es) 2007-10-10

Family

ID=35511278

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002808A MX2007002808A (es) 2004-09-10 2005-09-09 Proceso para el aislamiento de tacrolimus cristalino.

Country Status (9)

Country Link
US (1) US20080312447A1 (es)
EP (1) EP1786915A1 (es)
JP (1) JP2008512126A (es)
KR (1) KR20070057910A (es)
BR (1) BRPI0515695A (es)
CA (1) CA2580127A1 (es)
IL (1) IL181597A0 (es)
MX (1) MX2007002808A (es)
WO (1) WO2006031664A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007519758A (ja) * 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 結晶マクロライドの生成方法
US9044391B2 (en) * 2007-01-10 2015-06-02 Board Of Regents, The University Of Texas System Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
KR101003042B1 (ko) * 2008-03-17 2010-12-21 종근당바이오 주식회사 고순도 타크로리무스의 정제 방법
KR101022067B1 (ko) * 2008-05-30 2011-03-17 이연제약주식회사 고순도 타크로리무스의 회수방법
CN106478664B (zh) * 2016-08-29 2017-12-05 广东蓝宝制药有限公司 一种发酵液中提取纯化他克莫司的方法
CN112390817B (zh) * 2019-08-19 2023-07-07 鲁南制药集团股份有限公司 一种盐析萃取他克莫司发酵液的方法
CN114516884B (zh) * 2022-01-05 2024-03-19 福建省微生物研究所 一种高纯度他克莫司的提纯方法
KR102645011B1 (ko) 2023-10-17 2024-03-07 주식회사 라이프슈티컬 고상 추출법을 이용한 타크롤리무스의 정제방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
KR970002037B1 (ko) * 1994-12-09 1997-02-21 농촌진흥청 들깨유로부터 α-리놀렌산(ALA)을 분리, 정제하는 방법
DE60013434T2 (de) * 1999-05-25 2005-01-20 Fujisawa Pharmaceutical Co., Ltd. Verfahren zur trennung analoger organischer verbindungen
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds
EP1474404A4 (en) * 2002-02-13 2006-01-11 Biogal Gyogyszergyar PROCESS FOR EXTRACTION OF A BIOLOGICAL MATERIAL
WO2005019226A1 (en) * 2003-08-26 2005-03-03 Biocon Limited A process for the recovery of substantially pure tricyclic macrolide
CA2548297C (en) * 2003-12-05 2011-06-14 Biocon Limited Process for the purification of macrolides

Also Published As

Publication number Publication date
IL181597A0 (en) 2007-07-04
JP2008512126A (ja) 2008-04-24
WO2006031664A1 (en) 2006-03-23
EP1786915A1 (en) 2007-05-23
US20080312447A1 (en) 2008-12-18
BRPI0515695A (pt) 2008-03-04
KR20070057910A (ko) 2007-06-07
CA2580127A1 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
MX2007002808A (es) Proceso para el aislamiento de tacrolimus cristalino.
MY145604A (en) Process for the preparation of chiral 8-(3-aminopiperidine-1-yl)-xanthines
MX2015012865A (es) Metodos para purificacion de arn mensajero.
MY113405A (en) Production of sucralose without intermediate isolation of crystalline sucralose -6-ester
RS20050235A (en) Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
SG149061A1 (en) Definitive endoderm
WO2011075701A3 (en) Methods for the purification of deoxycholic acid
SG179101A1 (en) Novel peptides isolated from spider venom, and uses thereof
MX2009005664A (es) D-isoglutamil-d-triptofano cristalino, y la sal monoamonica de d-isoglutamil-d-triptofano.
EA200700139A1 (ru) Способ отделения и очистки цезия-131 от карбоната бария
WO2008140641A3 (en) Pure paliperidone and processes for preparing thereof
TN2012000259A1 (en) Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance
IL183933A0 (en) Process for the preparation fo galanthamine hydrobromide
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
EP1877544A4 (en) RECOVERY OF FABRIC FUNCTION AFTER ADMINISTRATION OF B-CELLS TO INJURED TISSUE
WO2007119120A3 (en) Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
AU2003293042A8 (en) Process for purification of plasmid dna
WO2008139228A3 (en) Process for the purification of olanzapine
WO2007128827A8 (en) 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies
EP1443053A4 (en) ANALGETIC ANTITUMORPEPTIDE FROM SCORPIONES AND METHOD FOR THE PRODUCTION THEREOF
WO2007026376A3 (en) A novel process for preparation of highly pure crystalline hydrochlorothiazide
WO2010122575A3 (en) Process for the preparation of pure paliperidone
MX2009004777A (es) Derivados de 18,21-didsesoximacbecina para el tratamiento de cancer.
PL2069382T3 (pl) Sposób selektywnego wydzielania, oczyszczania i rozdzielania monohydroksylowanych związków 3,17-diketosteroidowych
HK1126806A1 (en) Poly(ethylene glycol) functional derivatives and method of manufacturing the same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal